Limited benefit of treatment of diabetic polyneuropathy with an aldose reductase inhibitor: a 24-week controlled trial (original) (raw)

References

  1. Thomas PK, Eliasson SG (1984) Diabetic neuropathy. In: Dyck PJ, Thomas PK, Lambert EH, Bunge R (eds) Peripheral neuropathy. WB Saunders, Philadelphia, pp 1773–1810
    Google Scholar
  2. Pirart J (1977) Diabète et complications dégénératives présentation d'une étude prospective portant sur 4400 cas observés entre 1947 et 1973. Diabète Metab (Paris) 3: 97–107, 173–182, 245–256
    Google Scholar
  3. Gabbay KH, Merola LO, Field RA (1966) Sorbitol pathway: presence in nerve and cord with substrate accumulation in diabetes. Science 151: 209–210
    Google Scholar
  4. Handelsman DJ, Turtle JR (1981) Clinical trial of an aldose reductase inhibitor in diabetic neuropathy. Diabetes 30: 459–464
    Google Scholar
  5. Fagius J, Jameson S (1981) Effects of aldose reductase inhibitor treatment in diabetic polyneuropathy — a clinical and neurophysiological study. J Neurol Neurosurg Psychiatr 44: 991–1001
    Google Scholar
  6. Judzewitsch RG, Jaspan JB, Polonsky KS, Weinberg CR, Halter JB, Halar E, Pfeifer MA, Vukadinovic C, Bernstein L, Schneider M, Lian K-Y, Gabbay KH, Rubenstein AH, Porte D Jr (1983) Aldose reductase inhibition improves nerve conduction velocity in diabetic patients. New Engl J Med 308: 119–125
    Google Scholar
  7. Young RJ, Ewing DJ, Clarke BF (1983) A controlled trial of sorbinil, an aldose reductase inhibitor, in chronic painful diabetic neuropathy. Diabetes 32: 938–942
    Google Scholar
  8. Jaspan J, Maselli R, Herold K, Bartkus C (1983) Treatment of severely painful diabetic neuropathy with an aldose reductase inhibitor: relief of pain and improved somatic and autonomic nerve function. Lancet 2: 758–762
    Google Scholar
  9. Schouten JA, Hermans JJ, Popp-Snijders C, Boot H, van den Akker J, van der Veen EA (1984) A 3-month, placebo-controlled, efficacy study of sorbinil for diabetic neuropathy. Diabetologia 27: 329A
  10. Peterson MJ, Sarges R, Aldinger CE, MacDonald DP (1979) CP- 45, 634: A novel aldose reductase inhibitor that inhibits polyol pathway activity in diabetic and galactosemic rats. Metabolism 28 (Suppl): 456–461
    Google Scholar
  11. Agardh C-D, Rosén I, Scherstén B (1983) Improvement of peripheral nerve function after institution of insulin treatment in diabetes mellitus. Acta Med Scand 213: 283–297
    Google Scholar
  12. Foulds G, O'Brien MM, Bianchine JR, Gabbay KH (1981) Kinetics of an orally absorbed aldose reductase inhibitor, sorbinil. Clin Pharmacol Ther 30: 693–700
    Google Scholar
  13. Bergström J, Lindblom U, Norée L-O (1975) Preservation of peripheral nerve function in severe uremia during treatment with low protein high calorie diet and surplus of essential amino acids. Acta Neurol Scand 51: 99–109
    Google Scholar
  14. Lachman T, Shahani BT, Young RR (1980) Late responses as aids to diagnosis in peripheral neuropathy. J Neurol Neurosurg Psychiatr 43: 156–162
    Google Scholar
  15. Goldberg JM, Lindblom U (1979) Standardised method of determining vibratory perception thresholds for diagnosis and screening in neurological investigation. J Neurol Neurosurg Psychiatr 42: 793–80
    Google Scholar
  16. Fruhstorfer H, Lindblom U, Schmidt WG (1976) Method for quantitative estimation of thermal thresholds in patients. J Neurol Neurosurg Psychiatr 39: 1071–1075
    Google Scholar
  17. Fagius J, Wallin BG (1980) Sympathetic reflex latencies and conduction velocities in patients with polyneuropathy. J Neurol Sci 47: 449–461
    Google Scholar
  18. Mackay JD, Page MMcB, Cambridge J, Watkins PJ (1980) Diabetic autonomic neuropathy. The diagnostic value of heart rate monitoring. Diabetologia 18: 471–478
    Google Scholar
  19. Pfeifer MA, Cook D, Brodsky J, Tice D, Reenan A, Swedine S, Halter JB, Porte D Jr (1982) Quantitative evaluation of cardiac parasympathetic activity in normal and diabetic man. Diabetes 31: 339–345
    Google Scholar
  20. Wålinder O (1980) A rapid microchromatographic method for determination of hemoglobin A1. Upsala J Med Sci 85: 151–158
    Google Scholar
  21. Fagius J, Wahren LK (1981) Variability of sensory threshold determination in clinical use. J Neurol Sci 51: 11–27
    Google Scholar
  22. Halar EM, DeLisa JA, Brozovich FV (1980) Nerve conduction velocity: Relationship of skin, subcutaneous and intramuscular temperatures. Arch Phys Med Rehab 61: 199–203
    Google Scholar
  23. Mayer JH, Tomlinson DR (1983) Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myoinositol or an aldose reductase inhibitor in streptozotocin-diabetic rats. Diabetologia 25: 433–438
    Google Scholar
  24. Finegold D, Lattimer SA, Nolle S, Bernstein M, Greene DA (1983) Polyol pathway activity and myo-inositol metabolism. A suggested relationship in the pathogenesis of diabetic neuropathy. Diabetes 32: 988–992
    Google Scholar
  25. Yue DK, Hanwell MA, Satchell PM, Turtle JR (1982) The effect of aldose reductase inhibition on motor nerve conduction velocity in diabetic rats. Diabetes 31: 789–794
    Google Scholar
  26. Tomlinson DR, Moriarty RJ, Mayer JH (1984) Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor sorbinil. Diabetes 33: 470–476
    Google Scholar
  27. Clarke BF, Ewing DJ, Campbell IW (1979) Diabetic autonomic neuropathy. Diabetologia 17: 195–212
    Google Scholar
  28. Cicmir I, Kashiwagi S, Berger H, Koschinsky T, Gries FA (1983) Improvement of autonomic nerve functions after one year of continuous subcutaneous insulin infusion. Diabetologia 25: 147 (Abstract)
    Google Scholar
  29. Sachse G, Neuzner J, Federlin K (1983) Long-term effect of continuous subcutaneous insulin infusion therapy on the autonomic diabetic neuropathy of the cardiovascular system. Diabetologia 25: 191 (Abstract)
    Google Scholar
  30. Gabbay KH (1973) Role of sorbitol pathway in neuropathy. In: Camerini-Dávalos RA, Cole HS (eds) Vascular and neurological changes in early diabetes. Academic Press, New York, pp 417–424
    Google Scholar
  31. Clements RS Jr (1982) Myoinositol metabolism in diabetic neuropathy. In: Goto Y, Horiuchi A, Kogure K (eds) Diabetic neuropathy. Excerpta Medica, Amsterdam, pp 19–25
    Google Scholar
  32. Winegrad AI, Simmons DA, Martin DB (1983) Has one diabetic complication been explained? New Engl J Med 308: 152–154
    Google Scholar
  33. Vlassara H, Brownlee M, Cerami A (1981) Nonenzymatic glycosylation of peripheral nerve protein in diabetes mellitus. Proc Natl Acad Sci 78: 5190–5192
    Google Scholar
  34. Tuck RR, Schmelzer JD, Low PA (1984) Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy. Brain 107: 935–950
    Google Scholar

Download references